CRYGN (crystallin gamma N) is a structural protein of the vertebrate eye lens 1. As a member of the beta/gamma-crystallin superfamily, CRYGN contains Greek key motifs and plays a role in lens development and visual perception. Structurally, CRYGN occupies an intermediate evolutionary position, encoding the first two Greek key motifs by individual exons while encoding subsequent motifs by single exons 1. Mutations in CRYGN and related gamma-crystallin genes primarily lead to cataract formation through lens opacification, with evidence suggesting that altered gamma-crystallins form amyloid-like intranuclear inclusions that disrupt secondary lens fiber differentiation, resulting in retained cell nuclei 1. Emerging evidence indicates CRYGN may have functions beyond the lens. A bioinformatics analysis identified CRYGN among five differentially expressed genes significantly associated with glioblastoma prognosis, suggesting a potential role in brain tumor progression 2. Additionally, anti-CRYGN autoantibodies were associated with initial insomnia in psychotic disorder patients, indicating possible neuroimmune involvement 3. Prenatal tobacco smoke exposure was nominally associated with altered CRYGN DNA methylation in childhood asthmatics 4, suggesting epigenetic regulation may influence CRYGN expression during development. While CRYGN's primary function remains lens structural integrity, these findings warrant investigation of extraocular roles.